Abo Bibliothek: Guest
Critical Reviews™ in Oncogenesis

Erscheint 4 Ausgaben pro Jahr

ISSN Druckformat: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Iron Chelation: Inhibition of Key Signaling Pathways in the Induction of the Epithelial Mesenchymal Transition in Pancreatic Cancer and Other Tumors

Volumen 18, Ausgabe 5, 2013, pp. 409-434
DOI: 10.1615/CritRevOncog.2013007921
Get accessGet access

ABSTRAKT

Pancreatic cancer is the fourth leading cause of cancer-related deaths worldwide in both men and women. It presents late with non-specific symptoms, which makes it difficult to diagnose until the cancer has progressed and metastasized. Metastasis is facilitated by the epithelial-to-mes-enchymal transition (EMT), which is promoted via the oncogenic transforming growth factor beta (TGFβ), Wnt, and nuclear factor kappa B (NFκB) signaling pathways. However, recent studies have demonstrated that the EMT can be inhibited by novel anti-cancer agents known as thiosemicarbazone iron chelators. These novel agents also up-regulate the metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), which can restore normal signaling to the cell and suppresses metastasis via inhibition of the EMT. Through the ability of iron chelators to up-regulate NDRG1 expression and affect multiple molecular targets, these agents have the potential to maintain the epithelial phenotype of cancer cells and may lead to improved survival rates for patients with late-stage disease.

REFERENZIERT VON
  1. Fang Bernard A., Kovačević Žaklina, Park Kyung Chan, Kalinowski Danuta S., Jansson Patric J., Lane Darius J.R., Sahni Sumit, Richardson Des R., Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1845, 1, 2014. Crossref

  2. Beguin Yves, Aapro Matti, Ludwig Heinz, Mizzen Lee, Österborg Anders, Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis—A critical review, Critical Reviews in Oncology/Hematology, 89, 1, 2014. Crossref

  3. Zhang Shuping, Chen Yue, Guo Wenli, Yuan Lin, Zhang Daoqiang, Xu Yong, Nemeth Elizabeta, Ganz Tomas, Liu Sijin, Disordered hepcidin–ferroportin signaling promotes breast cancer growth, Cellular Signalling, 26, 11, 2014. Crossref

  4. Chang Xiaojing, Xu Xiaoyang, Ma Jinguo, Xue Xiaoying, Li Zhenhua, Deng Peng, Zhang Shuanglong, Zhi Yu, Chen Jing, Dai Dongqiu, NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells, Molecular Biology Reports, 41, 9, 2014. Crossref

  5. Chang Xiaojing, Xu Xiaoyang, Xue Xiaoying, Ma Jinguo, Li Zhenhua, Deng Peng, Chen Jing, Zhang Shuanglong, Zhi Yu, Dai Dongqiu, NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9, Pathology & Oncology Research, 22, 4, 2016. Crossref

  6. Xue Xiang, Shah Yatrik Madhukar, Iron, Cancer, and Hypoxia-Inducible Factor Signaling, in Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals, 2017. Crossref

  7. Park Kyung Chan, Fouani Leyla, Jansson Patric J., Wooi Danson, Sahni Sumit, Lane Darius J. R., Palanimuthu Duraippandi, Lok Hiu Chuen, Kovačević Zaklina, Huang Michael L. H., Kalinowski Danuta S., Richardson Des R., Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics, Metallomics, 8, 9, 2016. Crossref

  8. Paluncic Jasmina, Kovacevic Zaklina, Jansson Patric J., Kalinowski Danuta, Merlot Angelika M., Huang Michael L.-H., Lok Hiu Chuen, Sahni Sumit, Lane Darius J.R., Richardson Des R., Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863, 4, 2016. Crossref

  9. Park Kyoung‐Joo J., Kim James, Testoff Thomas, Adams Joseph, Poklar Miranda, Zborowski Maciej, Venere Monica, Chalmers Jeffrey J., Quantitative characterization of the regulation of iron metabolism in glioblastoma stem‐like cells using magnetophoresis, Biotechnology and Bioengineering, 116, 7, 2019. Crossref

  10. Dong Xueyi , Hong Yuheng , Sun Huizhi , Chen Chen , Zhao Xiulan , Sun Baocun , NDRG1 suppresses vasculogenic mimicry and tumor aggressiveness in gastric carcinoma, Oncology Letters, 2019. Crossref

  11. Xu Shenbin, Wang Zefeng, Ye Juan, Mei Shuhao, Zhang Jianmin, Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma, Frontiers in Oncology, 11, 2021. Crossref

  12. Trudu Federica, Amato Filippo, Vaňhara Petr, Pivetta Tiziana, Peña-Méndez E.M., Havel Josef, Coordination compounds in cancer: Past, present and perspectives, Journal of Applied Biomedicine, 13, 2, 2015. Crossref

  13. Pita-Grisanti Valentina, Chasser Kaylin, Sobol Trevor, Cruz-Monserrate Zobeida, Understanding the Potential and Risk of Bacterial Siderophores in Cancer, Frontiers in Oncology, 12, 2022. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain